Company Research Report: PARI Respiratory Equipment

Company Overview

Name: PARI Respiratory Equipment, Inc.

Mission: PARI is dedicated to providing effective aerosol therapy solutions to improve the lives of individuals affected by respiratory diseases, leveraging over 100 years of experience and expertise in the field.

Founded: No specific founding date provided. The company has been a trusted brand in respiratory therapy for more than 100 years.

Key People: No information is available.

Headquarters: Midlothian, VA, USA and Monterey, CA, USA. The parent group is based in Starnberg, Germany with additional locations in Weilheim and Gräfelfing.

Number of Employees: No information is available.

Revenue: No information is available.

What the Company is Known For: PARI is recognized worldwide as a leader in aerosol therapy, particularly known for developing clinically proven inhalation devices used widely in treating respiratory conditions such as asthma, COPD, and cystic fibrosis. They are known for their contribution to clinical trials and the safety and efficacy of new medications.

Products

PARI offers a range of products focused on inhalation therapy, including:

1. Nebulizer Systems

• Description: Devices that deliver aerosolized medication directly to the lungs.

• Key Features: Clinically proven effectiveness in delivering respiratory medication therapy.

2. eFlow Technology Partnering

• Description: Optimized vibrating membrane nebulizers developed for innovative medication delivery.

• Key Features: Partnered with the pharmaceutical industry for drug-device combination products, known for its breath-triggered nebulizer platform which optimizes drug delivery.

3. PRONEB Max

• Description: A nebulizer model with enhanced design features.

• Key Features: A sleek new design, lower operating temperature, suitable for multiple treatments per day.

4. Holding Chambers/Spacers and Aerosol Masks

• Description: Devices that enhance aerosol delivery, particularly in pediatric and sensitive population groups.

5. Airway Clearance Devices

• Description: Devices aimed to aid in the removal of mucus from airways.

Recent Developments

1. Product Launches:

• eFlow Integrated Nebulizer Platform: A newly introduced nebulizer platform that integrates the latest innovations in nebulizer technology designed for optimized drug delivery.

2. New Features:

• The introduction of digital therapy management with the PARI Connect system to improve device usability and therapeutic outcomes.

• Launch of the PARI Breath Guide app to increase adherence and enhance therapeutic results.

3. Partnerships/Collaborations:

• Strong partnership with pharmaceutical companies to develop and market nebulized therapies. Hosting more than 25 ongoing drug-nebulizer development projects.

Additional Information

Global Reach:

• PARI products are available in over 80 countries and can be purchased from various international distributors and service partners worldwide.

Customer Support: Comprehensive support available for distributors and service partners, including online ordering systems for ease of access to products and parts.

Research and Innovation: PARI has been recognized for its innovative strength by the Research Subsidy Certification Office, receiving a certification that highlights its contribution to research and development.

Social Media Presence: Active on platforms like LinkedIn and YouTube, ensuring engagement and information dissemination to stakeholders and potential users.

This report provides an insight into the legacy, product offerings, and innovative pursuits of PARI Respiratory Equipment, focusing on its leadership in aerosol therapy.